The Government is putting $24 million into science research focused on AI and biotechnology — work it expects will lead to products and businesses that help New Zealanders, not just stack up academic papers.

Prime Minister Christopher Luxon has been talking about this idea for months. In January, he told Parliament he wants the science system to commercialise — turn ideas into things people can use and buy. He returned to that theme in May, telling business leaders he expects researchers to work more closely with companies and adopt good ideas faster, wherever they come from.

The $24 million is definite. What research teams will actually get the money, which agencies will hand it out, and how the Government will measure whether it worked — those details aren't public yet.

This investment is part of a bigger push the Government is making across the science system. Luxon has been arguing that too much bureaucracy and red tape slow things down, not just money shortfalls. He wants to cut through institutional inertia — the way large organisations resist change — through faster consent processes and other measures.

New Zealand's research sector has a well-known problem. Our scientists are good at doing research: they publish papers, win international recognition. But we're poor at turning that research into commercial products that make money. This gap has been noted in every major review of the science system since at least 2011. Luxon is betting that if you give researchers more money for work that leads to products — and you push organisational culture to value that — things will change in a way they haven't before.

There's also a China angle worth knowing. Luxon has been talking up AI and technology connections with China at business summits. By making the New Zealand science system more commercially focused, the country looks like a better partner for foreign investment in technology — including from China-linked investors. That relationship carries political sensitivities the Government has been careful about.

The logic tying these pieces together makes sense on paper. Whether $24 million is actually enough to change how researchers work is another question. Science in New Zealand happens across universities, Crown research institutes, and independent research organisations. Each of them has its own way of doing things and its own incentives. Past efforts to push the science system toward commercialisation through funding alone haven't fully worked. The culture inside those institutions, and the rules around who owns new inventions, matter just as much as money.

What the Government has done is put real money behind a clear direction, with the Prime Minister consistently saying it matters. Whether that actually changes how the science system operates day-to-day — the rules for funding, what researchers are expected to deliver, how commercial arrangements work — or whether the money just flows through existing systems with new labels, is the real test. Previous governments have tried similar things. This time will show whether things actually move.